SCOTUS weighs if the ADA protects a retired worker’s claim over health benefits. Could post-employment policies spark future ADA battles? Chime in! #ADA#SCOTUS#EmployeeBenefits
California’s “state-made” insulin is stuck in limbo. While the schedule slips, prices are already dropping. Is this plan still worth it? Chime in! #Insulin#DrugPricing#HealthPolicy
@HHSGov unveils its AI game plan for healthcare, but the future is murky under President Trump’s policies. Will smarter tech & new guidelines truly transform care or stall out? Share your view! #AI#Healthcare#Innovation
@DEAHQ’s new telehealth rule sparks debate! Special registrations are set for prescribing controlled substances online, but strict limits worry providers. Could it curb misuse or just block patients needing care? Share your view!
#Telehealth#Healthcare#Regulations
Will 2025 be healthcare’s turning point? AI rules remain hazy, Medicare telehealth faces renewal drama, and cyber threats loom. Could strong M&A or IPOs bring relief? Let’s debate!
#HealthIT#DigitalHealth#Telehealth
Tie Medicare Pay to Inflation?
A new plan suggests using the Medicare Economic Index to keep docs afloat. Still short of covering real costs, but is it a step in the right direction?
#Medicare#PhysicianPay#HealthPolicy
@USSupremeCourt Unanimously sides with Employers on Overtime - No “clear and convincing” standard needed—just a preponderance of evidence. Will your FLSA strategy shift now? #HR#LegalUpdate#WorkplaceCompliance
Per Aura, in 2M+ job postings for 2025, “communication” is #1. Employers still want AI know-how, but soft skills win out. Is your resume ready for both? #Upskilling#CareerMove#AI
Amwell sells its psychiatric care segment to Avel eCare for $21M. CEO bets on focusing core services to boost cash flow by 2026. Can this pivot spark new momentum in telehealth? #Telehealth#MentalHealth#Innovation
UnitedHealth’s shareholders now question the cost of coverage denials vs. bottom lines. Is it time for a system overhaul? #Insurance#Healthcare#Coverage
Auto Dealer vs. Big Pharma: A Miami-based company is suing insulin makers & PBMs over alleged price inflation. Could this case spark big changes in how we pay for meds? Share your thoughts on fair pricing. #Insulin#DrugCosts#Litigation
5 days in the office?! @jpmorgan joins the no-flex RTO club, following finance peers in pushing full in-person schedules. Do you think this signals a lasting trend or a potential burnout trigger? #RTO#Leadership#OfficeLife
Top health search of 2024? “Is bronchitis contagious?” with 176k monthly searches! Other trending queries: water intake, blood pressure, and lupus. Surprised mental health didn’t make the list? What’s your take on these trends? 🤔 #HealthcareTrends#DigitalHealth#Wellness
New year, higher drug costs: Over 250 meds saw price hikes as of Jan. 1, 2025. While most rises stay below 10%, the U.S. still pays the most for prescriptions. How will this impact patients in 2025? #HealthcareCosts#DrugPrices#Pharma
Join us on Tuesday, January 21, 2025, at 1:00 pm ET for a webinar on effective strategies for reducing workplace injuries and cutting costs in the hospitality industry.
Register Here: https://t.co/8H6hl5xHrV
#RiskManagement#WorkplaceSafety#Hospitality
The Biden admin halts proposed changes to birth control benefits rules after 44k+ public comments. The debate over access and organizational policies continues. How should the next steps look? #HealthcarePolicy#BirthControlAccess#EmployeeBenefits
Nearly 50% of workers admit to taking or considering a "quiet vacation"—time off without using PTO. Burnout, anxiety, and rigid policies are driving this trend. Should companies rethink how they encourage PTO? #BurnoutPrevention#WorkLifeBalance#FutureOfWork
Per @hrdive, 80% of companies will track office attendance in 2024, with 95% enforcing compliance. Are happy hours enough to win employees back, or is flexibility & compensation the real key? What’s your take? #FutureOfWork#ReturnToOffice#EmployeeEngagement
Stricter GLP-1 coverage in 2025: As costs soar, insurers like Kaiser and BCBS cut weight-loss drug coverage. With 42% of adults eligible, is this sustainable cost management or a barrier to health equity? Let’s discuss. #GLP1Drugs#HealthcareCosts#WeightLoss